Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$36.95 - $82.41 $61,447 - $137,047
-1,663 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$135.05 - $182.59 $97,100 - $131,282
719 Added 76.17%
1,663 $248,000
Q3 2021

Nov 04, 2021

SELL
$145.58 - $192.14 $324,352 - $428,087
-2,228 Reduced 70.24%
944 $137,000
Q2 2021

Aug 12, 2021

BUY
$134.22 - $202.37 $384,406 - $579,587
2,864 Added 929.87%
3,172 $621,000
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $38,952 - $50,419
308 New
308 $44,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.